BRD4, along with BRD2 and BRD3, acts as an epigenetic reader in order to regulate gene transcription; particularly, since BET target genes’ products actively participate in key cellular processes involving cell cycle control, DNA repair, cell growth, cancer and inflammation, small molecule BET inhibitors (BETis) have drawn researchers’ attention lately [74]. The gene discussed is DNER; the disease is cancer.